Having trouble accessing articles? Reset your cache.

Effient prasugrel: Additional Phase III data

A subgroup analysis of 1,454 patients treated with Plavix clopidogrel in the Phase III TRITON-TIMI 38 trial showed that patients who were either homozygous for the C3435T variant in

Read the full 294 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE